Skip to main content
Premium Trial:

Request an Annual Quote

Bionano Genomics Stratys System, Via Software

Bionano Genomics has launched the Stratys system for high-throughput optical genome mapping and the Via software for analyzing genomic data for hematologic malignancies.

The Stratys instrument will have up to fourfold greater data output than the current Saphyr platform. It enables the use of up to 12 single-access chips and will be available to early-access customers in the second half of 2023.

The Via software, which replaces the current NxClinical software and will be available at the end of July, allows for the visualization, interpretation, and reporting of optical genome mapping, microarray, and sequencing data for hematologic malignancies.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.